A $78 million project to renovate two empty buildings at the former pharmaceutical research complex at the University of Michigan, known as the North Campus Research Complex, was recently approved by the UM board of regents. The 101,000 square feet of renovated space will be used to create more than 50 modern research laboratories for UM Medical School researchers.Read More
Science Market Update
The University of Minnesota has been awarded a five-year $8.2 million grant from the The National Cancer Institute (NCI) to develop a cell migration simulator that will predict how cancer cells move throughout the body.Read More
The $10 million gift from Andrew M. and Jane M. Bursky will advance cutting-edge research at the newly named Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs. Research at the center focuses on harnessing the immune system to fight cancer, infectious diseases, and autoimmune disorders.Read More
Tags: Washington University, Missouri, Washington University in St. Louis, new research funding, cancer research, infectious diseases, Immune System, MO, Midwest Region, immune system research, Washington Univsersity St. Louis, cancer therapy
According to the American Cancer Society, 1 in 8 American women will develop invasive breast cancer in their lifetime, and each year over 40,000 women die from it. However, thanks to research conducted at the University of Illinois Urbana-Champaign, the number of deaths due to breast cancer may soon be significantly reduced.Read More
Dr. Stefan Sarafianos, a professor of Molecular Microbiology and Immunology at the University of Missouri, was recently awarded a research grant of $3 million from the National Institutes of Health to develop new drugs to treat Hepatitis B (HBV).Read More
A team of researchers led by Gaya Amarasinghe, associate professor of Pathology and Immunology at Washington University School of Medicine, was recently awarded a $13 million NIH grant to study the replication process of the Ebola virus.Read More
Collaborative research projects across engineering and biomedicine are elevating Michigan State University's status as a top research institution thanks to its newly constructed Bio Engineering Facility.Read More
Tags: Michigan State University, Midwest, new research building, Midwest life science marketing events, Michigan, MI, MSU, new Building, Midwest Region, Michigan State, MSU – MSU, 2016, BioResearch Product Faire, bioengineering
Proton beam therapy is a form of targeted cancer treatment that has fewer debilitating side effects than traditional radiotherapy. The Mayo Clinic is a world-class center for cancer research and care in the Midwest, and now it will expand its holdings to include two new proton beam therapy centers, one in Rochester and another at its sister clinic in Phoenix. The type of advanced pencil beam scanning therapeutic equipment that the Mayo Clinic Proton Beam Therapy Center will use is very expensive (the two facilities will have a combined total cost of over $400M for 8 treatment rooms), and the $100 Million outright gift from philanthropist Richard O. Jacobson made earlier this year will go a considerable way toward advancing the project's progress.
Intensity-modulated proton beam therapy is less damaging to the cancer patient's healthy cells (surrounding the cancerous growth) because:
In 2009 the University of Michigan bought the shuttered Pfizer campus adjacent to its North (Ann Arbor) Campus for $108 Million. The 174-acre, 30-building, 2-million-square-feet of research and administrative space have since been renamed the North Campus Research Complex, and the Complex' Venture Accelerator has just opened with five startup companies as tenants. The 16,000 sf Accelerator facility is designed to fast-track new businesses based on UM technology by providing lab and office space, IT infrastructure, business services, and mentorship. The Accelerator is a branch of U-M's Tech Transfer, which also moved onto the new campus, along with the Business Engagement Center and the Medical School Business Development.